InstructorRoyed Training
TypeOnline Course
Price$390 USD / 22500 INR
Buy NowBook Now
biopharma valuation training course


Who should attend


Core Learning Area

Related Courses

This online training course provide understanding of valuation techniques that are commonly applied in the pharma and biotech industries.

This course provides comprehensive skill training for business development managers working in biopharmaceutical industry. Biopharma Valuation course covers biopharmaceutical business and brand valuation tools and techniques. Moreover course provides hands on training on biopharma business development deal identification, valuation and strategic planning process.

In these online self-paced modules, participants also understand about how to do forecasting of the early stage compounds. In other words, you will understand how effectively how to do valuation for discovery stage compounds. Moreover, this course focuses on how to devise and plan royalty in biopharma deal. Therefore, it helps advance professionals to acquire cutting edged business skills. 

Self Paced Learning

This  course utilizes interactive learning tools to guide participant to understand of the brand valuation process in biopharmaceutical business atmosphere. The course will focus on understanding business development skills which is required for  effective functioning as BD personnel in business development department. This online training will adopt a practical and interactive approach that will enable you to apply what you have learned to your daily work. The steps of approval process in details. The course will challenge the students to apply what they have learned through the use of interactive exercises, reflection questions, simulation and a final assessment at the end of the course.

This bio pharmaceutical business development course provide detailed training on biopharma valuation tools and techniques.

The course can be completed at any pace, allowing the user to stop and start at their leisure.

  • Title of the course: Advanced Certification in Biopharma Valuation
  • Course Code: RYD-037
  • Type of the course: Self paced Online Course
  • Duration: 1 Month
  • Certification: Course certificate will be issued on completion of the course.

Who should attend this course? 

  • This course is ideal for those who are working in business development and licensing department.
  • Professionals from strategic management. Those working in strategic management department in pharmaceutical and biopharmaceutical company. 
  • Most importantly this course provides valuable insight to those who are working on early stage discovery project and want hands on training on valuating discovery stage compounds.
  • Those who are in the regulatory affairs and related department, and looking for change into business development department. 
  • This biopahrma valuation management course is ideal for the senior management professionals working in pharmaceutical and biopharmaceutical project management.
  • Anyone requiring an overview and detail understanding on working of IPR, Inlicensing, Outlicensing and Technology Transfer Department. 

  • Online 24×7 access from anywhere. Hence, one can learn at your convenience.
  • The course provides timing flexibility. In other words, one can attend the lecture sessions at your own convenient time.
  • The course is build on interactive e-learning. Hence, it helps user to understand of the concepts effectively.
  • Above all, course provides simulation for real life working. Hence, it helps user to apply the decision making skill in real life scenarios.

Core Learning Areas in Biopharma Valuation Training

  • Scope and agenda development for the course.
  • Introduction to assessing company and valuation
  • Fundamental understanding on Return on investment (ROI)
  • Risk vs. return
  • Valuation Model for – Pharmaceutical and Biopharmaceutical companies
  • Focus on the most used company valuation methods
  • Discount Cash Flows
  • Market / Deal comparable
  • Case based understanding on valuation
  • Difference between company valuation and product valuation
  • Concept of DCF, CCA, Terminal Value, Net Present Value (NPV) Vs. Risk-adjusted Net Present Value (rNPV)
  • Benchmarking
  • How to calculate the value of a company from several product valuations
  • Deal Structuring
  • upfront payment
  • Milestone payments
  • Royalties

Section 1Fundamental of Biopharma Valuation : Identify, Profiling, Valuation of Early stage assets
Lecture 1Pharma R&D Process & Introduction to drug discovery
Lecture 2Business Development Job Functionality | Strategic Planning Process | Knowledge Area of Business Development | Lead targeting | Licensing term sheets
Lecture 3Portfolio Management Process | Portfolio Characteristics | Portfolio Analysis | Balancing the Portfolio | BD and Strategic Planning Department 
Lecture 4Identifying the corporate Need of business development | Objective – Strategy - Tactics | Portfolio constraints | SWOT | Numerical SWOT
Lecture 5Profiling and Searching | Objectives | Search Database | Creating Opportunity Anatomy for deal analysis | Mind Mapping | Searching Tools and Techniques - Web Search | Conference | Confidentaility - CDA | MTA
Lecture 6Numerical SWOT Practical training
Lecture 7Types of Deal from Drug Discovery to Commercialization
Lecture 8Training on Basic Finance  |  Understanding Financial Statement | Income Statement | Balance Sheet | Cash Flow Statement
Lecture 9Orientation on Biopharma Market Access
Lecture 10Introduction to Pharmacoeconomics | Different Types of Economic Evaluation | Cost-effectiveness plane | Economic modeling |Sensitivity Analysis | One way sensitivity analysis | Probabilistic sensitivity analysis 
Lecture 11Economic Evaluation Methods | Various methods | Importance of perspective in health economics | Discounting | Uncertainty 
Lecture 12Core fundamentals of Health Economics | Clinical and economic burden | Public Health Care Payer Vs. Patient and Societal | Positioning a new treatment with the current treatment | QALY | ICER | Threshold value | Clinical trials vs health economics assessment
Lecture 13QALY | How to calculate QALY | Importance and Significance 
Lecture 14ICER | How to calculate ICER | Importance and Significance | Incremental Effectiveness determination 
Lecture 15Pharmacoeconomic Evaluation Checklist | Health Economics Map | Economic evaluation cycle | Checklist of economic evaluation | Costs and Outcome relevant to different groups | Comparators | Problem of choosing the comparators
Lecture 16Pharmacoeconomic Evaluation - Resource and Cost | Fixed, Variable and Total Cost | Calculation | Average vs. marginal cost | Importance of marginal cost | Discounting | Discounting calculation | Preferable discounting rate | Sources of unit cost data | Reference costs
Lecture 17Pharmacoeconomic Evaluation - Benefits and Outcome | C/E Ratio | Intermediate Vs. Final Outcome | Sources of Effectiveness Data | QALY | Utility Weight | WTP | VPF | ATP | Difference between WTP & ATP 
Lecture 18Pharmaco-economic evaluation – analysis and results | Different Types of Models | Understanding Decision Tree - Components with practical Example | Markov model 
Lecture 19CER and PCOR
Section 2Forecasting
Lecture 20New Product Forecast Algorithm
Lecture 21Patient Based Forecasting Model | Applying more filters and variables
Lecture 22Prescription Based Forecasting Model | Differences between Patient Based and Prescription Based Forecasting Model | Which model to use and when?
Lecture 23Prevalence Vs. Incidence Model
Lecture 24EPI Based Forecasting | Sales Based Forecasting | When and where to apply which forecasting model
Lecture 25Sales Forecasting Tools | New Product Forecasting | In Market Forecasting
Lecture 26Market Size Assignment 1 [Oncology Brand] - Applying sales forecasting tools to carry out next 6 years sales forecast | Excel Based Model
Lecture 27Market Size Assignment 2 [Asthma Brand] - Applying sales forecasting tools to carry out multiple years sales forecast | Excel Based Model
Lecture 28Patient Based Model Vs. Patient Flow Model | Critical Differences in Model | Concept of Black Box in Patient Flow Model | Application of both model
Lecture 29Bottom-up or Top-down Forecasting | LRx | Significance of LRx data analysis
Lecture 30Simulation on Bottom-up forecasting
Lecture 31Assessment on Bottom-up forecasting
Lecture 32Portfolio Based Forecasting | Forecasting Model Development in Excel 
Section 3Valuation
Lecture 33Modelling and Deal Valuation - Top Down Model | Epidemiology data method | Complex Model | Forecasting | Heuristic or ‘prophesy’ method | Different value perspectives | Deal Structuring Structuring the deal
Lecture 34Royalty Management - Royalty structuring | Royalty Calculation Method| Tiered Royalties | Terms | Royalty Reductions | Royalty Stacking - Concept and Calculation | Minimum Annual Royalties | Reach through royalties
Lecture 35Average Royalty Rate
Lecture 36Factor affecting the Royalty Rate in Pharmaceutical and Biopharmaceutical Deal
Lecture 37Factors affecting royalty rate
Lecture 38Acquisition in Pharma  | Product Acquisition| Company Acquisitions| Steps in acquisition | Financing acquisition deals | Trademark Assignment Process
Lecture 39Acquisition in Pharma  | Product Acquisition| Company Acquisitions| Steps in acquisition | Financing acquisition deals | Trademark Assignment Process
Lecture 40Licensing Term Sheet | Content Structuring | Sample Term Sheet
Lecture 41Licensing Payment Schedule | Case Study 
Lecture 42Valuation Methods: DCF | rNPV | Sunk Cost Method | Comparables | Sum of Parts | Deterministic Vs. Probabilistic rNPV |  Peak Sales - Max-Min Approach
Lecture 43Valuation Methods: EBITDA method of valuation | Enterprise Value and Enterprise Multiple Calculation
Lecture 44Business Development Simulation and Decision Making | Early Stage VS. Late Stage Valuation Methodology | Stair Step Model
Lecture 45Licensing Agreement : Confidentiality Agreement | MTA | A deed of Assignment | Exclusive | Non-Exclusive License | Sole License | Components - Terms - Duration - Key Considerations
Lecture 46Value Share Principle | Discounting of licensing deal | Discount Rate 
Lecture 47DCF Calculation : Concept and Calculation - Step by step understanding
Lecture 48Net Present Value (NPV) method : Calculation
Lecture 49Risk-Adjusted Discount Rate Method - Calculation | Concept of Risk Premium
Lecture 50Valuation Metric - P/E Ratio and EPS : Calculation
Lecture 51Comparable Company Analysis method : Calculation
Lecture 52Benchmarking | Benchmarking through consortium | How to use benchmarking for drug discovery development projects